Getting your ADCs to the clinic: Consideration for early stage development

2 Dec 2013 at Holiday Inn Bloomsbury, London, United Kingdom

Health & Fitness, Medical & Health Care

Submit new post
Thank you for posting.
Share it:

Speakers ({{speakersCount}})

Show all

The development of existing or novel monoclonal antibodies as drug-conjugates to increase the targeted clinical effect of these proteins has rapidly increased in recent years. Over 30 antibody–drug conjugates (ADCs) are being tested in the clinic in a range of oncology indications. In the absence of specific guidance on the development of antibody-drug conjugates, this workshop aims to help participants

From: December 02, 2013 08:30
To: December 02, 2013 13:30

Holiday Inn Bloomsbury, Coram Street, WC1N 1HT, London, United Kingdom


Health & Fitness, Medical & Health Care